Literature DB >> 23572441

Disutility of illness for caregivers and families: a systematic review of the literature.

Eve Wittenberg1, Lisa A Prosser.   

Abstract

BACKGROUND: Caring for an ill or disabled family member imposes a well-documented burden on the caregiver. The benefits of a health intervention may be underestimated if "spillover" effects on family members are not captured, resulting in inaccurate conclusions of economic evaluations.
OBJECTIVE: To provide an estimate of, and to summarize measurement approaches for, the spillover disutility of illness on family members, relatives, and caregivers, through a systematic review of the literature.
METHODS: The medical (PubMED), psychology (PsycINFO), and economics (EconLit) literatures were searched from inception through February 2012 for published studies measuring spillover disutility of illness on family members and caregivers. Inclusion criteria were (1) studies using preference-based measures of health-related quality of life, and (2) studies reporting spillover disutility, or (3) studies reporting data from which a spillover disutility could be inferred.
RESULTS: Fifteen studies were included in this review: seven reported estimates of spillover disutility and eight reported data from which disutility could be inferred. Three studies found no disutility associated with spillover, whereas 12 found measurable effects as large as -0.718 (and two found evidence of positive spillover in subsets of their samples). Generic (indirect) utility instruments were primarily used to measure spillover, including the EQ-5D, QWB, and HUI (n = 13), though two studies used modified versions of the time trade-off technique. Illnesses studied included childhood disorders (e.g., spina bifida, congenital malformations), diseases of the elderly (e.g., Alzheimer's disease and dementia), physically disabling conditions (e.g., arthritis, multiple sclerosis), and medical conditions such as cancer and stroke. The persons affected by spillover included parents, grandparents, spouses/partners, other family caregivers, and household members.
CONCLUSIONS: There is a limited literature on the spillover disutility of illness on family members and caregivers, providing some specific estimates of a generally small, negative effect for particular conditions and individuals. Measurement methods vary across studies and a consensus approach has not yet been reached. Evidence suggests that the inclusion of spillover effects in economic evaluations would increase the relative effectiveness of interventions that address conditions with spillover compared to those without, though such differential benefits may be limited to such specific circumstances.

Entities:  

Mesh:

Year:  2013        PMID: 23572441      PMCID: PMC3674134          DOI: 10.1007/s40273-013-0040-y

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  49 in total

1.  Social networks and collateral health effects.

Authors:  Nicholas A Christakis
Journal:  BMJ       Date:  2004-07-24

2.  Is a family equal to the sum of its parts? Estimating family-level well-being for cost-effectiveness analysis.

Authors:  Amy E Bonomi; Denise M Boudreau; Paul A Fishman; Richard T Meenan; Dennis A Revicki
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

3.  Too important to ignore: informal caregivers and other significant others.

Authors:  Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  Implications of spillover effects within the family for medical cost-effectiveness analysis.

Authors:  Anirban Basu; David Meltzer
Journal:  J Health Econ       Date:  2005-04-22       Impact factor: 3.883

5.  Lung cancer patients and their spouses: psychological and relationship functioning within 1 month of treatment initiation.

Authors:  Cindy L Carmack Taylor; Hoda Badr; Ji H Lee; Frank Fossella; Katherine Pisters; Ellen R Gritz; Leslie Schover
Journal:  Ann Behav Med       Date:  2008-09-17

6.  Caring for and caring about: disentangling the caregiver effect and the family effect.

Authors:  Ana Bobinac; N Job A van Exel; Frans F H Rutten; Werner B F Brouwer
Journal:  J Health Econ       Date:  2010-06-01       Impact factor: 3.883

Review 7.  Caregiver burden among dementia patient caregivers: a review of the literature.

Authors:  Lynn Etters; Debbie Goodall; Barbara E Harrison
Journal:  J Am Acad Nurse Pract       Date:  2008-08

8.  Sisters in hereditary breast and ovarian cancer families: communal coping, social integration, and psychological well-being.

Authors:  Laura M Koehly; June A Peters; Natalia Kuhn; Lindsey Hoskins; Anne Letocha; Regina Kenen; Jennifer Loud; Mark H Greene
Journal:  Psychooncology       Date:  2008-08       Impact factor: 3.894

9.  Evidence of spillover of illness among household members: EQ-5D scores from a US sample.

Authors:  Eve Wittenberg; Grant A Ritter; Lisa A Prosser
Journal:  Med Decis Making       Date:  2012-10-25       Impact factor: 2.583

Review 10.  The burden of schizophrenia on caregivers: a review.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

View more
  37 in total

1.  Carer preferences in economic evaluation and healthcare decision making.

Authors:  Hareth Al-Janabi; Nikki McCaffrey; Julie Ratcliffe
Journal:  Patient       Date:  2013       Impact factor: 3.883

2.  Spillover Effects on Caregivers' and Family Members' Utility: A Systematic Review of the Literature.

Authors:  Eve Wittenberg; Lyndon P James; Lisa A Prosser
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

3.  Parental Health Spillover in Cost-Effectiveness Analysis: Evidence from Self-Harming Adolescents in England.

Authors:  Sandy Tubeuf; Eirini-Christina Saloniki; David Cottrell
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

4.  The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra.

Authors:  Werner B F Brouwer
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

5.  Expanding the Scope of Costs and Benefits for Economic Evaluations in Health: Some Words of Caution.

Authors:  Christopher McCabe
Journal:  Pharmacoeconomics       Date:  2019-04       Impact factor: 4.981

Review 6.  An emerging field of research: challenges in pediatric decision making.

Authors:  Ellen A Lipstein; William B Brinkman; Alexander G Fiks; Kristin S Hendrix; Jennifer Kryworuchko; Victoria A Miller; Lisa A Prosser; Wendy J Ungar; David Fox
Journal:  Med Decis Making       Date:  2014-08-21       Impact factor: 2.583

Review 7.  EQ-5D in Central and Eastern Europe: 2000-2015.

Authors:  Fanni Rencz; László Gulácsi; Michael Drummond; Dominik Golicki; Valentina Prevolnik Rupel; Judit Simon; Elly A Stolk; Valentin Brodszky; Petra Baji; Jakub Závada; Guenka Petrova; Alexandru Rotar; Márta Péntek
Journal:  Qual Life Res       Date:  2016-07-29       Impact factor: 4.147

8.  Utility Estimation for Pediatric Vesicoureteral Reflux: Methodological Considerations Using an Online Survey Platform.

Authors:  Rohit Tejwani; Hsin-Hsiao S Wang; Jessica C Lloyd; Paul J Kokorowski; Caleb P Nelson; Jonathan C Routh
Journal:  J Urol       Date:  2016-10-13       Impact factor: 7.450

9.  Impact of In-Hospital Death on Spending for Bereaved Spouses.

Authors:  Katherine A Ornstein; Melissa M Garrido; Albert L Siu; Evan Bollens-Lund; Kenneth M Langa; Amy S Kelley
Journal:  Health Serv Res       Date:  2018-02-28       Impact factor: 3.402

10.  Measuring benefits of opioid misuse treatment for economic evaluation: health-related quality of life of opioid-dependent individuals and their spouses as assessed by a sample of the US population.

Authors:  Eve Wittenberg; Jeremy W Bray; Brandon Aden; Achamyeleh Gebremariam; Bohdan Nosyk; Bruce R Schackman
Journal:  Addiction       Date:  2015-12-17       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.